Skip to content

Guardian Pharmacy Services GRDN Q4 2024 Annual earnings

Reported March 26, 2025 · After market close

Revenue estimate$323.1M
EPS estimate$0.21

Next report

Aug 10, 2026 (in a month)
Revenue estimate$340.4M
EPS estimate$0.26

Financials

Q4 2024

Income statement

See full
Revenue$338.6M+20.5%
Gross profit$67.1M+23.0%
Net income--100%

Balance sheet

See full
Cash & equivalents$4.7M+520%
Total debt$37.3M-33.5%
Total equity$150.0M
Total assets$320.8M+18.3%

Cash flow

See full
Operating cash flow$22.3M+53.5%
CapEx$2.3M+814%
Free cash flow$20.1M+38.0%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.28B
Enterprise value$1.32B
P/S

Profitability

See full
Gross margin19.9%
Net margin-9.4%

Returns & leverage

See full
Debt / equity0.2×
Current ratio1.1×+0.1×

Segments

By segment

See full
Corporate$338.6M+29.4%

Versus estimates

Ask the moment Guardian Pharmacy Services reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Guardian Pharmacy Services report Q4 2024 earnings?
Guardian Pharmacy Services (GRDN) reported Q4 2024 earnings on March 26, 2025 after market close.
What were Guardian Pharmacy Services's Q4 2024 revenue and EPS?
Guardian Pharmacy Services reported revenue of $338.6M and diluted EPS of $0.24 for Q4 2024.
Did Guardian Pharmacy Services beat estimates in Q4 2024?
Revenue beat the consensus estimate of $323.1M by $15.5M. EPS beat the consensus estimate of $0.21 by $0.03.
Where can I find Guardian Pharmacy Services's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001193125-25-064082) directly on SEC EDGAR. The filing index links above go to sec.gov.